Europe Anti-Rheumatics Market Forecast 2020-2028

Publisher Name :
Date: 03-Apr-2020
No. of pages: 115

KEY FINDINGS

The Europe anti-rheumatics market is predicted to reach a CAGR of 2.10% over the forecast period of 2020-2028. A huge patient base of rheumatoid arthritis, owing to a large geriatric population, is one of the crucial factors favoring the market growth in the region.

MARKET INSIGHTS

The Europe anti-rheumatics market is researched further by segmenting the region into countries such as France, Russia, the UK, Poland, Germany, Belgium, Italy, and the rest of Europe that comprises of Greece, Austria, Netherland, Switzerland, Spain, Ireland, among others. In Russia, the prevalence of RA is estimated at 0.61% and has remained stable over the years. RA has been associated with many humanistic outcomes in spite of its low prevalence. Rheumatic disease is the second most common pathology after cardiovascular disorders, with 10% of the population being affected by RD. The most common RDs are osteoarthritis, rheumatoid arthritis, gout, and low back pain. The major factors responsible for the rising prevalence of RDs are hypertension, obesity, diabetes mellitus, and others. In countries like Belgium, the RA deaths accounted for 0.07% of the total deaths. Currently, around 80,000 to 100,000 people have this medical condition in Belgium. Since there is no known cure for RA, physicians focus on suppressing the disease. Therapies have improved in recent years, and intensive treatment in the early stages of RA can prevent joint damage and improve quality of life. The rapid improvement in therapy is driving the market.

In Poland, the most widely used DMARDs is methotrexate, which, in accordance with EULAR recommendations, is administered in RA treatment. Moreover, the program for the treatment of GPA and MPA was introduced, thereby promoting the market growth. The prevalence of RA, together with the increasing healthcare facilities, are propelling the market growth in the rest of Europe.

COMPETITIVE INSIGHTS

F. Hoffmann-La Roche Ltd, Abbott Laboratories, Novartis International AG, UCB, Becton, Dickinson, and Company, etc. are some of the renowned companies functioning in the market.

Europe Anti-Rheumatics Market Forecast 2020-2028

Table of Contents

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Rising Geriatric Population
3.2.2. Surge In The Prevalence Of Rheumatoid Arthritis Disease
3.2.3. Growing Healthcare Expenditure
3.3. Key Restraints
3.3.1. Patent Expirations
3.3.2. Lack Of Regulatory Guidelines For Biosimilars Will Delay Their Availability In Some Regions
3.3.3. Less Expensive Alternatives
4. Key Analytics
4.1. Porter's Five Force Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer's Power
4.1.4. Supplier's Power
4.1.5. Competitive Rivalry
4.2. Etiology Of Rheumatoid Arthritis (Ra)
4.3. Symptoms Of Rheumatoid Arthritis
4.4. Risk Factors Associated With Rheumatoid Arthritis
4.5. Opportunity Matrix
4.6. Vendor Landscape
4.7. Key Investment Insights
5. Market By Type
5.1. Prescription-Based Drugs
5.2. Over-The-Counter Drugs
6. Market By Drug Class
6.1. Disease Modifying Anti-Rheumatic Drugs
6.2. Nonsteroidal Anti-Inflammatory Drugs
6.3. Corticosteroids
6.4. Uric Acid Drugs
6.5. Other Drug Class
7. Geographical Analysis
7.1. Europe
7.1.1. The United Kingdom
7.1.2. France
7.1.3. Germany
7.1.4. Italy
7.1.5. Russia
7.1.6. Belgium
7.1.7. Poland
7.1.8. Rest Of Europe
8. Company Profiles
8.1. Abbott Laboratories
8.2. Abbvie Inc
8.3. Amgen Inc
8.4. Becton, Dickinson & Company (Bd)
8.5. Bio-Rad Laboratories Inc
8.6. Bristol-Myers Squibb Company
8.7. Eli Lilly & Company
8.8. Lupin Limited
8.9. F. Hoffmann-La Roche
8.10. Johnson & Johnson
8.11. Merck & Co Inc
8.12. Novartis Ag
8.13. Perkinelmer
8.14. Pfizer Inc
8.15. Ucb

List of Tables

Table 1: Market Snapshot - Anti-Rheumatics
Table 2: Common Symptoms Of Rheumatoid Arthritis
Table 3: Risk Factors For Rheumatoid Arthritis
Table 4: Europe Anti-Rheumatics Market, By Type, Historical Years, 2016-2019 (In $ Million)
Table 5: Europe Anti-Rheumatics Market, By Type, Forecast Years, 2020-2028 (In $ Million)
Table 6: Europe Prescription-Based Drugs Market, Historical Years, 2016-2019 (In $ Million)
Table 7: Europe Prescription-Based Drugs Market, Forecast Years, 2020-2028 (In $ Million)
Table 8: Europe Over-The-Counter Drugs Market, Historical Years, 2016-2019 (In $ Million)
Table 9: Europe Over-The-Counter Drugs Market, Forecast Years, 2020-2028 (In $ Million)
Table 10: Europe Anti-Rheumatics Market, By Drug Class, Historical Years, 2016-2019 (In $ Million)
Table 11: Europe Anti-Rheumatics Market, By Drug Class, Forecast Years, 2020-2028 (In $ Million)
Table 12: Europe Disease Modifying Anti-Rheumatic Drugs Market, Historical Years, 2016-2019 (In $ Million)
Table 13: Europe Disease Modifying Anti-Rheumatic Drugs Market, Forecast Years, 2020-2028 (In $ Million)
Table 14: Europe Nonsteroidal Anti-Inflammatory Drugs Market, Historical Years, 2016-2019 (In $ Million)
Table 15: Europe Nonsteroidal Anti-Inflammatory Drugs Market, Forecast Years, 2020-2028 (In $ Million)
Table 16: Europe Corticosteroids Market, Historical Years, 2016-2019 (In $ Million)
Table 17: Europe Corticosteroids Market, Forecast Years, 2020-2028 (In $ Million)
Table 18: Europe Uric Acid Drugs Market, Historical Years, 2016-2019 (In $ Million)
Table 19: Europe Uric Acid Drugs Market, Forecast Years, 2020-2028 (In $ Million)
Table 20: Europe Other Drug Class Market, Historical Years, 2016-2019 (In $ Million)
Table 21: Europe Other Drug Class Market, Forecast Years, 2020-2028 (In $ Million)
Table 22: Europe Anti-Rheumatics Market, By Country, Historical Years, 2016-2019 (In $ Million)
Table 23: Europe Anti-Rheumatics Market, By Country, Forecast Years, 2020-2028 (In $ Million)

List of Figures

Figure 1: Porter's Five Force Analysis
Figure 2: Opportunity Matrix
Figure 3: Vendor Landscape
Figure 4: Key Investment Insights
Figure 5: Europe Anti-Rheumatics Market, By Type, In 2019
Figure 6: Europe Anti-Rheumatics Market, By Prescription-Based Drugs, 2020-2028 (In $ Million)
Figure 7: Europe Anti-Rheumatics Market, By Over-The-Counter Drugs, 2020-2028 (In $ Million)
Figure 8: Europe Anti-Rheumatics Market, By Drug Class, In 2019
Figure 9: Europe Anti-Rheumatics Market, By Disease Modifying Anti-Rheumatic Drugs, 2020-2028 (In $ Million)
Figure 10: Europe Anti-Rheumatics Market, By Nonsteroidal Anti-Inflammatory Drugs, 2020-2028 (In $ Million)
Figure 11: Europe Anti-Rheumatics Market, By Corticosteroids, 2020-2028 (In $ Million)
Figure 12: Europe Anti-Rheumatics Market, By Uric Acid Drugs, 2020-2028 (In $ Million)
Figure 13: Europe Anti-Rheumatics Market, By Other Drug Class, 2020-2028 (In $ Million)
Figure 14: Europe Anti-Rheumatics Market, Country Outlook, 2019 & 2028 (In %)
Figure 15: The United Kingdom Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 16: France Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 17: Germany Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 18: Italy Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 19: Russia Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 20: Belgium Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 21: Poland Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 22: Rest Of Europe Anti-Rheumatics Market, 2020-2028 (In $ Million)
  • Global Ketogenic Diet Therapeutics Market Growth (Status and Outlook) 2020-2025
    Published: 29-May-2020        Price: US 3660 Onwards        Pages: 139
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Native Bacterial Antigens Market Growth (Status and Outlook) 2020-2025
    Published: 29-May-2020        Price: US 3660 Onwards        Pages: 116
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Insulin Glargine and Lispro Market Growth 2020-2025
    Published: 29-May-2020        Price: US 3660 Onwards        Pages: 132
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Immunosuppressants API Market Growth 2020-2025
    Published: 29-May-2020        Price: US 3660 Onwards        Pages: 131
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Oral Hypoglycemic Drugs Market Growth 2020-2025
    Published: 29-May-2020        Price: US 3660 Onwards        Pages: 164
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Animal Rabies Vaccine Market Growth 2020-2025
    Published: 29-May-2020        Price: US 3660 Onwards        Pages: 138
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Ketogenic Diet Market Growth (Status and Outlook) 2020-2025
    Published: 29-May-2020        Price: US 3660 Onwards        Pages: 138
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Methenamine Hippurate Tablets Market Growth 2020-2025
    Published: 29-May-2020        Price: US 3660 Onwards        Pages: 137
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Agricultural Animal Vaccine Market Growth 2020-2025
    Published: 29-May-2020        Price: US 3660 Onwards        Pages: 165
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs